Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin by Becker, Lukas et al.






The following full text is a publisher's version.
 
 









Thermodynamic Stability Is a Strong Predictor for the Delivery
of DARPins to the Cytosol via Anthrax Toxin
Lukas Becker 1, Jasleen Singh Badwal 1, Fabian Brandl 1 , Wouter P. R. Verdurmen 2 and Andreas Plückthun 1,*


Citation: Becker, L.; Singh Badwal, J.;
Brandl, F.; Verdurmen, W.P.R.;
Plückthun, A. Thermodynamic
Stability Is a Strong Predictor for the
Delivery of DARPins to the Cytosol
via Anthrax Toxin. Pharmaceutics 2021,
13, 1285. https://doi.org/10.3390/
pharmaceutics13081285
Academic Editors: Alyssa Panitch
and Piroska Szabó-Révész
Received: 22 June 2021
Accepted: 5 August 2021
Published: 18 August 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Biochemistry, University of Zurich, Winterthurerstr. 190, 8057 Zurich, Switzerland;
l.becker@bioc.uzh.ch (L.B.); j.singhbadwal@bioc.uzh.ch (J.S.B.); brandl.fabian@gmail.com (F.B.)
2 Department of Biochemistry, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University
Medical Center, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands;
wouter.verdurmen@radboudumc.nl
* Correspondence: plueckthun@bioc.uzh.ch
Abstract: Anthrax toxin has evolved to translocate its toxic cargo proteins to the cytosol of cells
carrying its cognate receptor. Cargo molecules need to unfold to penetrate the narrow pore formed
by its membrane-spanning subunit, protective antigen (PA). Various alternative cargo molecules
have previously been tested, with some showing only limited translocation efficiency, and it may be
assumed that these were too stable to be unfolded before passing through the anthrax pore. In this
study, we systematically and quantitatively analyzed the correlation between the translocation of
various designed ankyrin repeat proteins (DARPins) and their different sizes and thermodynamic
stabilities. To measure cytosolic uptake, we used biotinylation of the cargo by cytosolic BirA, and
we measured cargo equilibrium stability via denaturant-induced unfolding, monitored by circular
dichroism (CD). Most of the tested DARPin cargoes, including target-binding ones, were translocated
to the cytosol. Those DARPins, which remained trapped in the endosome, were confirmed by CD
to show a high equilibrium stability. We could pinpoint a stability threshold up to which cargo
DARPins still get translocated to the cytosol. These experiments have outlined the requirements for
translocatable binding proteins, relevant stability measurements to assess translocatable candidates,
and guidelines to further engineer this property if needed.
Keywords: anthrax toxin; cytosolic protein delivery; DARPin; circular dichroism; protein stability
1. Introduction
Anthrax toxin is an AB-type bacterial holotoxin of Bacillus anthracis. It comprises two
protein components with distinct functions: a catalytically active and toxic A component
that relies on the cell-binding and pore-forming B component, protective antigen (PA).
There are two toxic A components: lethal factor (LF) and edema factor (EF). Upon cellular
binding of PA, furin or furin-like proteases induce oligomerization of PA by cleaving off
the 20 kDa domain 1. Three or four LF or EF moieties are able to bind to the oligomerized
PAs, the prepore, consisting of seven or eight PA63 subunits [1]. This LF- and EF-bound
prepore complex is taken up by the cells via clathrin-mediated endocytosis [2]. Due to
the pH shift within the endosome, the PA prepore restructures and inserts a β-barrel-like
pore into the membrane, which helps to unfold and translocate the bound LF and EF cargo
through the pore [3].
The modular structure of anthrax toxin enabled us and others to generate engineered
PA variants with altered cell specificity and the capability to translocate alternative LF
cargo molecules [4–9]. Our group and others [6,10–13] showed that cytosolic translocation
by pore-forming toxins depends on the ability of the molecule to fit through this channel.
Therefore, multiple factors block translocation, such as unfolding influenced by protein
cargo stability [11]; the presence of disulfide bridges [14]; strong negative charges that
cannot be temporarily protonated, such as cysteic acid (pKa = −1.9) [15]; and general
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bulkiness, as exemplified for nonprotein cargoes by cyclic peptides or a bulky small-
molecule drug such as docetaxel [16]. The inability of anthrax toxin to deliver those protein
cargo molecules thus lies in the prerequisite of cargo unfolding for the translocation, as
passage through the PA pore is catalyzed by the narrow 6 Å clamp consisting of Phe
residues, termed a phi (Φ)-clamp, via a charge-state-dependent Brownian ratchet [17–19].
Using the biotin ligase assay [20] to quantify cytosolically delivered cargo molecules,
we investigated quantitatively to what extent the thermodynamic stability of the cargo is a
predictor for successful delivery via PA pores. Specifically, our aim was to evaluate how
stable a cargo molecule can be yet still be efficiently translocated. To systematically evaluate
this relationship, we used designed ankyrin repeat proteins (DARPins), for which there
is a great variety of potential cargo proteins available with different sizes and stabilities
to define a potential stability translocation threshold. We show here that DARPin cargo
proteins up to a ∆G0 value of around 10 kcal mol−1, representing the change in Gibbs
free energy between the folded and unfolded states, can be translocated very efficiently
to the cytosol, with more stable cargoes progressively demonstrating a poorer cytosolic
translocation. Furthermore, we show that DARPins can be rationally destabilized to reach
this threshold and are then efficiently translocated, without losing their folded structure or
binding affinity.
2. Materials and Methods
2.1. Cell Lines
Flp-In 293 cells, stably overexpressing EpCAM and BirA (Flp-In 293-EpCAM-BirA [6]),
were cultured using DMEM. The medium was supplemented with 10% fetal calf serum,
100 IU/mL penicillin, and 100 µg/mL streptomycin.
2.2. Cloning
Cloning of most constructs used in this study has been described before [6,9]. DARPin
cargoes were cloned into the SpeI/AgeI-restricted pQIq-LFN-cargo-avi-HA backbone for
protein delivery. For CD spectroscopy, DARPins were cloned via SpeI/AgeI in a pQIq
expression vector without LFN, avi, or HA-tag.
2.3. Protein Expression
Expression of His6-MBP-PAwt-sANTXR-Ac2 and His6-MBP-LFN-cargo constructs has
been described before [6,9]. For the expression of DARPins for CD spectroscopy, the E. coli
strain BL21 was transformed with described plasmids. A single clone was picked the next
day and used for an overnight culture in LB medium, supplemented with 100 µg/mL
ampicillin at 37 ◦C. A 500 mL volume of LB medium, supplemented with 100 µg/mL
ampicillin, was inoculated with 10 mL overnight culture and grown at 37 ◦C until an OD600
of 0.8 was reached. Protein expression was induced with 500 µM IPTG and incubated for
4 h at 30 ◦C. Cultures were centrifuged for 10 min at 5000 g at 4 ◦C, the pellet washed with
PBS, pH 7.4, snap-frozen, and stored at −20 ◦C until purification.
2.4. Protein Purification
Purifications of His6-MBP-PAwt-sANTXR-Ac2 and His6-MBP-LFN-cargo constructs
have been described before [9]. All unfused DARPins were purified in a similar manner
at 4 ◦C. Tris-HCl buffers were adjusted to pH 8.0. Bacterial cell pellets were thawed and
resuspended in lysis buffer (50 mM Tris-HCl, 1 mM EDTA, 500 mM NaCl, 10% glycerol),
supplemented with 0.4 mM 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF). 100 µg/mL
DNase I and 1 g/L lysozyme were added. Cells were lysed by sonication and centrifuged
for 45 min at 20,000 g. DARPins were purified by their His-tag via immobilized metal
ion affinity chromatography (IMAC). HisPurTM Ni-NTA Resin (Thermo Scientific) was
packed in 2 mL benchtop columns (PD10), and columns were equilibrated in lysis buffer.
Lysate was applied to the column, washed with 10 column volumes (CV) high-salt buffer
(25 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole), 10 CV low-salt buffer (25 mM Tris-
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HCl, 125 mM NaCl, 20 mM imidazole), and eluted with 2.5 CV elution buffer (25 mM
Tris-HCl, 125 mM NaCl, 300 mM imidazole). DARPins were dialyzed overnight against
PBS, snap-frozen in liquid N2, and stored short term at −20 ◦C.
2.5. Biotin Ligase Uptake Assay
To quantitate the total cellular uptake, as well as the cytosolic localization of cargo
proteins, the biotin ligase assay was performed as described previously [20]. Cytosolic
uptake was determined by normalizing signal intensities of cytosolic uptake to the signal
intensity of the unspecific interaction of streptavidin with HSP70, which correlates well
with the actin signal [6]. To cross-compare the quantification from different delivery assays,
we normalized the quantified signals to the control (Cells only, 0%) and defined the signal
for NI1C, the smallest and best-delivered DARPin, as 100%.
2.6. CD Spectroscopy and Equilibrium Unfolding
Proteins were diluted in PBS with increasing concentrations of GdnHCl to a final
protein concentration of 10 µM. For CD spectroscopy analysis of DARPins at various pH
values, DARPins were diluted in 50 mM of the respective buffer (MES at pH 6.5 and pH
6.0, sodium acetate at pH 5.5, pH 5.0, pH 4.5 and pH 4.0 and citric acid at pH 3.5). All
buffers were supplemented with 150 mM NaCl. For CD spectroscopy analysis of DARPins
at pH 6, a buffer exchange was performed, prior to GdnHCl dilution, via PD10 columns
(GE Healthcare) to 50 mM MES (pH 6.0) and 150 mM NaCl.
Protein-GdnHCl solutions and protein solutions in different buffers were incubated
overnight at room temperature for the systems to equilibrate. The CD signal at 222 nm
was recorded on a Jasco J-715 instrument (Jasco, Japan) using a cylindrical quartz cell of
1 mm pathlength, 1 nm bandwidth, 4 s response time and 3 accumulations. Measurements
were baseline-corrected to the respective buffer and converted to mean residue ellipticity
(MRE). A nonlinear, least-squares fit was used (Equation (1)) to fit the unfolding curves
and determine ∆G0 and m.
yobs =
(
y f + m f [D]
)






Here y f , m f , yu, and mu describe the slope and intercept of the pre- and post-transition
baselines. The transition region is characterized by ∆GH2O and m. The slopes of the
baselines, m f and mu, were restrained to be zero. The denaturation midpoint (Dm) was




Values for ∆GH2O and m were obtained from the fits using Equation (1). If fitting
Equation (1) was not possible, i.e., when the protein did not behave as a two-state system,
Dm was estimated simply by a nonlinear (if required biphasic) fit (GraphPad Prism 8.0; X
is concentration) to experimental data, to guide the eye. Values for Dm estimated by this
latter fit are clearly labeled throughout this manuscript.
2.7. Surface Plasmon Resonance (SPR)
Binding kinetics of off7 and off7 dest1 were determined as previously described [21].
A 1:1 Langmuir binding model was fit to the data measured on a ProteOnTM XPR36
instrument (BioRad Laboratories, Hercules, CA, USA) with a ProteOnTM NLC Sensor Chip
(BioRad) using ProteOnTM Manager Software (Version 3.1.0.6, BioRad).
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3. Results
3.1. Cytosolic Translocation of LFN-DARPin Cargoes via PAwt-sANTXR-Ac2
Previously, we showed the delivery of consensus DARPins to the cytosol of Flp-
In 293-EpCAM-BirA cells stably overexpressing the epithelial cell adhesion molecule
(EpCAM) [6,9]. We developed PAwt-sANTXR-Ac2, a rationally designed PA variant retar-
geted to EpCAM [9], which does not prematurely form pores in the plasma membrane and
can thus transport significantly more cargo to the cytosol than previous targeted versions.
The translocation capability of PAwt-sANTXR-Ac2 (and of previous targeted PA variants)
was limited to those consensus DARPins with low enough thermodynamic stability, but no
quantitative assessment was carried out. Consensus DARPins with two or three internal
repeats could be efficiently translocated only upon introducing destabilizing mutations
in the DARPin framework, as consensus DARPins were originally engineered for very
high stability [6,22]. However, no threshold value of equilibrium stability had been de-
termined. In these consensus molecules, surface residues additionally contribute to the
stability through charge interactions. In contrast, target-selected binders have a more varied
surface and usually still have high stability, but not as high as the consensus molecules [23],
and thus it was important to establish the transport capability of target-binding DARPins
as well.
Here, we investigated the relation between DARPin cargo equilibrium stability and the
translocation ability of PAwt-sANTXR-Ac2 with different cargo DARPins. Cargo DARPins
were fused to the C-terminus of the PA-binding domain of lethal factor 1–254 (LFN), and
they contain the biotin-acceptor avi-tag and an HA-tag at their C-terminus. LFN-cargoes
consisted of consensus DARPins, LoopDARPins, and target-selected DARPins, and they
varied in their number of internal repeats and therefore in size and thermodynamic stability.
We utilized the biotin ligase assay to quantify cytosolic delivery, a Western-blot-
based method we previously published [20]. The biotin ligase assay relies on the stable
overexpression of a cytosolically localized biotin ligase derived from E. coli (BirA) and the
presence of an avi-tag on the cargo of interest, which gets biotinylated only when the cargo
is present in the cytosol, as it requires direct contact with the resident biotin ligase. To
perform this assay, we incubated Flp-In 293-EpCAM-BirA cells with PAwt-sANTXR-Ac2
and the respective cargo DARPins, fused to LFN, for 4 h in the presence of the proteasome
inhibitor MG-132. Cells incubated without PAwt-sANTXR-Ac2 or LFN-cargo fusions were
collected as controls. We used an LFN-eGFP fusion as a negative control for delivery due
to endosomal entrapment of this molecule, as it cannot be unfolded and pass through the
pore, as reported previously [9].
We first set out to investigate the translocation potential of a set of DARPins. Con-
firming earlier observations, the consensus DARPins with one and two internal repeats, as
well as mutations of the latter, get translocated to the cytosol (Figure 1, Figures S1a–j and
S2a–e). An LFN fusion construct designed with two identical NI1C DARPins in tandem,
LFN-NI1C-NI1C, also showed cytosolic delivery. The consensus DARPin with three internal
repeats does not show a signal for cytosolic localization, while destabilizing mutations
(NI3C dest1–5) restore efficient translocation, as shown previously [6]. The location of the
destabilizing mutations is listed for convenience in Table 1 and Figure S3a,b.
Several LoopDARPins and DARPins, all consisting of three internal repeats (N3C
format), were tested. DARPins 012_F12, 008_C6, 003_C9, off7, and a destabilized version of
it (off7 dest1, carrying the same mutations as NI3C dest1; Table 1) were translocated to the
cytosol. In contrast, the consensus DARPin NI3C was not translocated, nor DARPin 3G124,
selected to bind GFP [24], nor was DARPin J1_2_32, specific for c-Jun N-terminal kinases
(JNKs) [25]. However, translocation was observed for the JNK binder DARPin J1/2_2_25
with two internal repeats (N2C format).
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Figure 1. Quantification of Western blots shown in Supplementary Figure S1, measuring the delivery of different LFN-cargo
constructs with PAwt-sANTXR-Ac2 from a representative experiment. Cargo proteins delivered to the cytosol become
biotinylated by cytoplasmic BirA and are subsequently stained with Streptavidin IRDye 680LT. Cytosolic uptake was
determined by normalizing signal intensities of cytosolic uptake to the signal of the unspecific interaction of streptavidin
with HSP70, which correlates well with the actin signal, and thus can serve as an intrinsic calibration [6]. The delivered
cargo DARPin with one internal repeat (labeled “NI1C”) is used as a control for maximum signal intensity of cytosolic
uptake and cells without any delivered cargo (labeled “Cells”) as a negative control. The location of the mutations in the
destabilized (dest) DARPins is listed in Table 1, Figure S3b, and [6].
Figure 1 shows varying cytosolic signal intensities for the different DARPins. Cytosolic
degradation, among other factors, even in the presence of the proteasome inhibitor MG-132,
might influence the strength of cytosolically detected DARPin signals. Therefore, the BirA
assay is used here to distinguish between successful cytosolic translocation and endosomal
entrapment of cargo molecules, but not for a direct quantitative comparison of cytosolic
cargo concentrations, as discussed further below.
3.2. Denaturant-induced Equilibrium Unfolding of DARPin Cargoes
Based on the observation that three DARPins in N3C format (NI3C, J1_2_32, and
3G124) are not translocated via PAwt-sANTXR-Ac2, we investigated the equilibrium ther-
modynamic stability of the cargo DARPins by denaturant-induced unfolding. For this
purpose, the DARPins were incubated at 20 ◦C in PBS pH 7.4 in increasing concentrations
of guanidine hydrochloride (GdnHCl), and their unfolding was monitored using circular
dichroism (CD) at 222 nm. Figure 2a–f shows respective unfolding curves for the tested
cargo DARPins. Thermodynamic parameters of the cargo DARPins were analyzed assum-
ing two-state unfolding and fitting Equation (1) to the data. The calculated ∆G0, m-value,
and the denaturation midpoint concentration (Dm) are summarized in Table 1. DARPins
008_C6, off7, NI3C, and 3G124 are not well described by two-state equilibria; therefore,
we do not report a ∆G0 and m-value. For very stable N3C DARPins, this fact has been
explained by the C-cap unfolding already at lower denaturant concentrations than the
main transition [26], and for a LoopDARPin, it is possible that the cooperativity between
the ankyrin repeats is interrupted by the loop insertion. It should be noted that in the
present study, the stabilized C-caps [26] were not used, as too high stability of the cargo
was not desired.
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Figure 2. GdnHCl-induced equilibrium unfolding of various cargo DARPins in PBS (pH 7.4) at 20 ◦C, analyzed by CD
spectroscopy. Curves represent a fit to Equation (1). (a) LFN and the consensus DARPins NI1C, NI1C-NI1C, NI2C, and
NI2C dest2; (b) NI3C consensus DARPin and mutated variants of it (NI3C dest1–4); (c) target-selected LoopDARPins;
(d) MBP-binding DARPin off7 and a destabilized off7 variant; (e) JNK-binding DARPins and eGFP-binding DARPin 3G124;
(f) NI3C dest1 variants with repeat-specific mutations: dashed lines represent NI3C with no mutations (right) and NI3C
dest1 with all mutations (left). Destabilizing mutations (dest1–4) have been described before [6], and their location is listed
in Table 1.
LFN (not fused to another protein) is translocated to the cytosol. The individual LFN
subunit has a Dm of 0.9 M GdnHCl and a ∆G0 value of 3.6 kcal mol−1. The smallest
DARPin, NI1C, shows the highest signal for cytosolic localization and has the lowest ∆G0
value, 2.5 kcal mol−1. The NI1C-NI1C fusion, the DARPin cargo tested with the highest
nominal MW, has the same protein stability as the single NI1C DARPin, showing that the
two DARPins are indeed unfolding independently as expected, and the fusion protein is
efficiently translocated (Figures 1 and 2a, Table 1).
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Table 1. Parameters characterizing different cargo DARPins and LFN.
Protein FrameworkMutation a IR
b MW Dm ∆G0 m CL c Ref.
[kDa] [M] [kcal mol−1] [kcal mol−1 M−1]
LFN - - 32.4 0.9 3.6 4.1 Y [27]
NI1C - 1 11.1 1.3 2.5 2.0 Y [28]
NI1C-NI1C - 1-1 21.0 1.4 2.5 1.8 Y -
NI2C - 2 14.6 3.3 7.5 2.3 Y [28]
NI2C dest2 (L8A)1,2,3 2 14.5 1.7 4.2 2.5 Y [6]
J1/2_2_25 - 2 14.6 2.7 9.1 3.4 Y [25]
NI3C dest1 (L24A)1,2,3 3 18.0 2.7 7.6 2.8 Y [6]
NI3C dest11 (L24A)1 3 18.1 3.7 * - - N -
NI3C dest12 (L24A)2 3 18.1 3.7 * - - N -
NI3C dest13 (L24A)3 3 18.1 4.2 * - - N -
NI3C dest11,2 (L24A)1,2 3 18.0 3.0 * - - Y/N -
NI3C dest12,3 (L24A)2,3 3 18.0 3.6 * - - N -
NI3C dest2 (L24G)1,2,3 3 17.9 1.6 6.7 4.2 Y [6]
NI3C dest3 (L8A, L24A)1,2,3 3 17.8 1.6 6.4 4.1 Y [6]
NI3C dest4 (L8G, L24A)1,2,3 3 17.8 0.7 2.6 3.5 Y [6]
008_C6 - 3 18.2 2.1 * - - Y [29]
003_C9 - 3 18.3 1.5 3.3 2.2 Y [29]
012_F12 - 3 18.1 1.2 2.8 2.3 Y [29]
off7 - 3 18.1 3.6 * - - Y [21]
off7 dest1 (L24A)1,2,3 3 18.0 1.8 6.7 3.7 Y -
NI3C - 3 18.1 4.8 * - - N [28]
J1_2_32 - 3 18.0 3.4 10.1 3.0 N [25]
3G124 - 3 17.9 5.2 * - - N [24]
∆G0 and m were calculated from fits of Equation (1) to GdnHCl-induced equilibrium unfolding curves. Dm was
calculated using Equation (2). A two-state fit model could not reasonably be fitted to the DARPin data marked
with an asterisk (*); therefore, Dm was estimated based on the main unfolding step. Cytosolic localization was
determined with the BirA assay. a Repeat-specific numbering; b Number of internal repeats (IR); c Cytosolic
localization (CL) measured via BirA assay.
As described previously [28], the thermodynamic stability of DARPins increases with
the increasing number of internal repeats (Table 1). For DARPins with two internal repeats
(NI2C, NI2C dest1–6, and the selected binder J1/2_2_25), cytosolic localization can be
detected for all the tested constructs (Figure 1). Even the stable NI2C and J1/2_2_25,
with ∆G0 values of 7.5 kcal mol−1 and 9.1 kcal mol−1, respectively, can be unfolded
and translocated by PAwt-sANTXR-Ac2, although potentially with lower efficiency than
NI1C. Consensus DARPins carrying mutations in the framework (NI2C dest1–6) modestly
increased cytosolic localization signals. We therefore measured the unfolding curves for
only one of the destabilized NI2C DARPins, verifying that the framework mutations would
further reduce the stability, as described below for mutations introduced in the NI3C
consensus DARPin (Figure 2a,b), but because the stable NI2C is translocated, ∆G0 values
of further NI2C mutants would bring no further information on translocation efficiency.
The NI3C consensus DARPin is not translocated to the cytosol (Figure 1, Figure S1c,d) [6]
and shows a Dm of 4.8 M GdnHCl, but because it does not follow two-state unfolding, its
∆G0 cannot be determined from attempting such a fit [26]. The destabilizing mutations
introduced in the NI3C consensus DARPin (NI3C dest1–6, [6]) significantly lowered Dm
and ∆G0, and for these mutants, two-state unfolding seems to describe the unfolding
(Figure 2b, Table 1).
The introduction of single mutations in each of the three internal repeats (either L24A
in NI3C dest1 or L24G in NI3C dest2) reduced the stability of the DARPin to ∆G0 values
of 7.6 kcal mol−1 and 6.7 kcal mol−1, respectively. When two mutations are introduced
in each of the three internal repeats (combining L8A and L24A in NI3C dest3 or L8G and
L24A in NI3C dest4), a further decreased DARPin stability was measured, with a ∆G0 of
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6.4 kcal mol−1 for the NI3C dest3 or a ∆G0 of 2.6 kcal mol−1 for the NI3C dest4. The latter
is already equivalent to the level of a DARPin with a single internal repeat (Table 1).
The target-selected binders were obtained from libraries of N2C, N3C, and N3C Loop-
DARPin formats and thus differ in the target-binding surface and stability (Figure 2c,d).
DARPins J1_2_32 and 3G124 were not translocated to the cytosol and showed an equilib-
rium stability comparable to the consensus NI3C DARPin (Table 1). Having undergone
target selection, therefore, does not necessarily decrease ∆G0 to the point to allow translo-
cation through the pore formed by PAwt-sANTXR-Ac2. Nonetheless, many N3C binders
were translocated (008_C6, 003_C9, 012_F12, off7) without further modification, and if such
a further destabilization was carried out (off7 dest1), it did not further affect translocation.
The JNK-binding N2C DARPin J1/2_2_25 was translocated without modification, which
may not be surprising, as the stable consensus NI2C was translocated as well.
Because the introduction of a mutation in all three repeats of the NI3C consensus
DARPin backbone restored delivery to the cytosol, it was of interest to investigate whether
mutations in only one or two of the repeats might already be sufficient. We therefore
created variants of the NI3C dest1 with the L24A mutation only in the first (denoted with a
subscript, NI3C dest11), second (NI3C dest12), or third (NI3C dest13) repeat, or with two
L24A mutation in the first and second (NI3C dest11,2) or in the second and third (NI3C
dest12,3) internal repeat. We found that efficient cytosolic delivery was not restored with
these variants, and only the variant NI3C dest1, with all three internal repeats carrying the
L24A mutation, was detected in the cytosol (Figure 1, Figure S4a–c). We determined the
equilibrium stability of these mutated variants via denaturant-induced unfolding measured
by CD. As expected, we found them to be in between the variant NI3C dest1, which is
destabilized in all three internal repeats, and the consensus NI3C (Figure 2f, Table 1).
These findings indicate that all three internal repeats need to be mutated to restore efficient
delivery for the very stable NI3C consensus DARPin, but the intermediate unfolding curves
also show that a more subtle destabilization is possible, and a particular binder may be
rescued by such a small change.
One attractive feature of the DARPin structure is that these destabilizing mutations
can be introduced in the framework, away from target-contacting residues. Nonetheless,
we tested whether mutating all three internal repeats in these non-contacting residues
would influence target binding by measuring the binding kinetics by SPR. We compared
the DARPin off7 and the destabilized variant off7 dest1, carrying the same mutations
as the DARPin NI3C dest1 (Table 1). We determined a similar KD value for off7 dest1
(KD = 2.45 nM) compared to off7 (KD = 3.07 nM) without any mutation (Figure S5a,b, [21]),
confirming that mutations in the backbone of the DARPin do not influence its binding
affinity. Therefore, the DARPin structure permits one to introduce destabilizing mutations
(Figure 2d, Table 1) that still maintain the structure of the target-binding interface, as
they do not decrease target-binding affinity, and thus stability-determining residues and
affinity-determining residues can indeed be separated from each other.
Anthrax toxin translocates its cargo molecules through the endolysosomal membrane
to the cytosol. One of the driving forces of the transport mechanism is the pH difference
between the late endosomal compartment, around pH 6.0, and the neutral pH in the cytosol.
We therefore tested the DARPin integrity at different pH values, with a subset of DARPins
(NI1C, NI2C, NI3C, J1/2_2_25, and J1_2_32) and observed no changes in alpha-helical
content, for any DARPin tested, from pH 7.4 to pH 6.5 or pH 6.0 (Figure S6a–c). By further
decreasing the pH to pH 5.5 and finally stepwise down to pH 3.5, we observed partial
precipitation of these proteins that all have a low isoelectric point, and eventually, all
DARPins also showed a reduced alpha-helical structure (Figure S6d–h). This is probably
due to the critical histidine in the TLPH motif, which is part of every consensus ankyrin
repeat and highly conserved in ankyrins [22].
In order to further evaluate the influence of pH on the equilibrium unfolding behavior
of the cargo DARPins, the previously mentioned set of DARPins, additionally including
NI3C dest1, were tested for their equilibrium unfolding at pH 6.0 (Figure S7a). Their Dm
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was calculated, and all tested constructs showed very similar unfolding curves at pH 6.0
and pH 7.4 (Table 1, Figure S7b).
We further tested the equilibrium unfolding behavior of LFN-DARPin fusion con-
structs (Figure S8a) to confirm the independent unfolding of the LFN domain, and the
cargo DARPin. LFN-NI2C and LFN-NI3C fusion constructs confirm the independent un-
folding of the fusion partners. LFN unfolds in both fusion constructs at a Dm of 0.9 M
(Figure S8b), similar to the non-fused LFN (Table 1). For the consensus DARPins with two
and three internal repeats, a Dm of 3.5 M and 4.9 M (Figure S8b) was observed, similar
to the Dm of the DARPins alone (Table 1). For the LFN-NI1C fusion protein, a two-state
unfolding behavior was observed. Even though it is expected that LFN and NI1C DARPin
will also unfold independently, they share a similar Dm (1.0 M), and thus the curves will be
indistinguishable (Table 1, Supplementary Figure S8).
Having characterized various cargo DARPins for uptake and stability, we tested the
correlation between the normalized cytosolic signal intensity, shown in Figure 1, as well as
the Dm and ∆G0 (Table 1). Figure S9a,b confirms the overall trend that the more stable a
cargo DARPin is, the less efficiently it will be delivered. However, there are several factors
that contribute to deviations from this correlation. Because of the large number of samples,
we have to cross-compare Western blots, with increased uncertainties of quantification.
Furthermore, we are observing steady-state levels, and thus varying cytosolic degradation
rates will also impact the observed cytosolic levels.
4. Discussion
In this study, we provide an in-depth quantitative investigation of the relationship
between the potential to be delivered to the cytosol through the pore formed by PAwt-
sANTXR-Ac2 and the equilibrium thermodynamic stability of various DARPins. For
both properties, we tested consensus DARPins that had shown translocation in a previ-
ous study [6] and further expanded the range of cargoes to now include target-selected
DARPins, target-selected LoopDARPins, and a two-DARPin fusion cargo construct.
We confirmed our previous findings, showing that all DARPins with one or two
internal repeats are translocated to the cytosol of Flp-In 293-EpCAM-BirA cells overexpress-
ing EpCAM, using an EpCAM-retargeted PA fusion, PAwt-sANTXR-Ac2 [6]. The NI3C
consensus DARPin with three internal repeats is translocated only upon implementing
destabilizing mutations within the DARPin framework. The target-selected DARPins
confirmed these findings, as two of the tested N3C DARPins (with three internal repeats)
remain trapped in the endosome, while one did translocate, as did all target-selected
LoopDARPins with three internal repeats, as well as the above-mentioned DARPin with
two internal repeats.
In an earlier study, we hypothesized that lower thermodynamic stability of the
DARPin leads to a higher translocation up to a cutoff stability point. Destabilization
lower than this cutoff would not lead to higher translocation efficiency [6] (see below).
However, this threshold stability had not been measured. Therefore, we tested whether the
DARPin equilibrium stability could predict the ability of the anthrax pore to translocate
cargo molecules. Because LFN has naturally evolved to get translocated and itself has a
low equilibrium stability, and because the cargo unfolds independently in a fusion with
LFN, as found by the identical equilibrium denaturation curves, the cargo DARPin alone
determines the translocation. From the denaturant-induced equilibrium unfolding curves,
we could correlate stability and cytosolic translocation and found that only molecules
having a ∆G0 value of less than 10 kcal mol−1 showed a cytosolic signal. In contrast,
molecules with higher stability than this value, such as three of the N3C DARPins tested,
showed no translocation. This ∆G0 value is not reached by N1C or N2C molecules, as with
the increasing number of repeats, the stability of the DARPin increases [28], and thus all
N1C or N2C molecules were translocated.
A previous study further tested the unfolding rates of DARPin molecules, which
decreased with the increasing number of internal repeats [28]. This unfolding rate of cargo
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molecules might be an additional factor influencing cargo translocation, as endosomal
degradation might reduce the time available to unfold and translocate within the endo-
/lysosomal compartment. However, we currently do not have DARPins with the same
equilibrium ∆G0 but different folding and unfolding rates, and we cannot yet distinguish
kinetic and equilibrium effects. Because equilibrium unfolding of the tested DARPins
at an endosomal-like pH did not change the Dm of the DARPins, we deduce that our
measurements at neutral pH are relevant to describe the relative stability of the DARPins
at endosomal pH.
We hypothesized earlier [6] that DARPin library members with randomized residues
can be less stable than consensus DARPins and could thus get translocated without desta-
bilizing mutations even in the N3C format, as the consensus DARPins were specifically
designed and optimized for their stability [6,28,30]. Nonetheless, target-selected binders
were not necessarily less stable than their ’parental’ consensus variant [30]. Selected binders
for JNKs were available in both N2C and N3C format, and the N2C variants could be
delivered, while the N3C variant was too stable to get translocated [25,31]. Rational desta-
bilization of target-selected binders might thus be necessary for efficient translocation for
some N3C variants, and we showed that this can be achieved without losing target affinity.
We showed that eGFP was not translocated, and we thus used it as a negative control.
It forms a β-barrel structure, and previous studies have reported ∆G0 values for eGFP
above 10 kcal mol−1 [32], which is in the range of those DARPin cargoes that were not
translocated.
We could confirm that the size of the cargo DARPins does not limit translocation, at
least in the ranges tested. Fusing two NI1C DARPins to each other and to LFN resulted
in cytosolic translocation, even though this NI1C-NI1C fusion molecule is 3 kDa (MWcalc)
larger than the NI3C consensus DARPin, but it consists of independently unfolding do-
mains. These findings complement the results from our previous study, where we started
destabilizing the NI2C and NI3C consensus DARPin to show that stability might be more
important than size [6]. The equilibrium unfolding behavior of LF and LFN has been tested
before with differing results, depending on the buffer, pH, and fits used [33–35]. For LFN,
we measured a ∆G0 value of 3.6 kcal mol−1. We could confirm an uptake of proteins with
much higher stability than LFN, up to 10 kcal mol−1; however, the maximum size of a
cargo protein remains currently unknown. We propose that any protein below the stability
threshold, devoid of disulfide bridges and not larger than LF itself (90 kDa), is likely to
get translocated.
Another important factor to consider in destabilizing cargo molecules is the subse-
quent cytosolic refolding and stability of the protein in the cytosol. NI3C dest4 has two
mutations per internal repeat and is destabilized by more than would be needed for translo-
cation. If these mutations are introduced into a DARPin that recognizes a cytosolic target,
it might become too unstable to refold and to have a biologic effect in the cytosol and
instead be more prone to a faster proteolytic degradation in the cytosol. A suitable assay
for cytosolic refolding is therefore in high demand and currently under development. We
thus propose that for optimal intracellular binding activity, there is a certain window of
opportunity, characterized by maximum stability that allows unfolding in the endosome
concomitant with transport and minimum stability needed for efficient refolding in the
cytosol to escape proteolytic degradation.
5. Conclusions
The stability translocation threshold of anthrax-toxin-mediated delivery is correlated
to the equilibrium protein stability of the cargo, measured via denaturant-induced unfold-
ing. Combining our results from the biotin ligase assay and these thermodynamic stability
measurements, we identified a threshold range at about 10 kcal mol−1, above which cytoso-
lic translocation of DARPin cargoes becomes essentially undetectable. The measurement of
the DARPin stability therefore enables the design of translocatable DARPins for cytosolic
targets in a high-throughput manner, without having to test each individual one for its
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delivery in an initial screening. Furthermore, mutations can be introduced to destabilize
the DARPin just enough for translocation, while target binding can be maintained.
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via HA-tag of the LFN-cargo, Figure S3: Destabilizing mutations in DARPin framework, Figure S3:
Western blot and quantification showing delivery of different LFN-cargo constructs of the consensus
DARPin NI3C and variants of the NI3C dest1 with PAwt-sANTXR-Ac2, Figure S4: Western blot and
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variants of the NI3C dest1, Figure S5: SPR measurement of off7 and off7 dest1, Figure S6: pH titration
of different DARPins, Figure S7: GdnHCl-induced equilibrium unfolding at pH 6 of NI1C, NI2C,
NI3C, NI3C dest1, J1/2_2_25 and J1_2_32, Figure S8: GdnHCl-induced equilibrium unfolding of
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midpoint or ∆G0 of the DARPin.
Author Contributions: L.B.: Conceptualization, methodology, formal analysis, investigation, writing—
original draft preparation, writing—review and editing, visualization, supervision, project admin-
istration; J.S.B.: Methodology, formal analysis, investigation, writing—review and editing; F.B.:
Investigation, formal analysis, writing—review and editing, visualization; W.P.R.V.: Investigation,
writing—review and editing; A.P.: Conceptualization, writing—review and editing, supervision,
funding acquisition. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by Schweizerischer Nationalfonds, grant number 310030_192689.
Data Availability Statement: All data are included in this manuscript and its supplementary files.
Acknowledgments: We thank Erich Michel for his help and fruitful discussions about CD spec-
troscopy.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or
in the decision to publish the results.
Abbreviations
PA protective antigen




AEBSF 4-(2-aminoethyl) benzenesulfonyl fluoride
IMAC immobilized metal ion affinity chromatography
CV column volume
MRE mean residue ellipticity
Dm denaturation midpoint
SPR surface plasmon resonance
EpCAM epithelial cell adhesion molecule
LFN lethal factor 1–254
BirA biotin ligase derived from E. coli
dest destabilized




Pharmaceutics 2021, 13, 1285 12 of 13
References
1. Kintzer, A.F.; Thoren, K.L.; Sterling, H.J.; Dong, K.C.; Feld, G.K.; Tang, I.I.; Zhang, T.T.; Williams, E.R.; Berger, J.M.; Krantz,
B.A. The protective antigen component of anthrax toxin forms functional octameric complexes. J. Mol. Biol. 2009, 392, 614–629.
[CrossRef]
2. Friebe, S.; van der Goot, F.; Bürgi, J. The ins and outs of anthrax toxin. Toxins 2016, 8, 69. [CrossRef]
3. Feld, G.K.; Brown, M.J.; Krantz, B.A. Ratcheting up protein translocation with anthrax toxin. Protein Sci. 2012, 21, 606–624.
[CrossRef] [PubMed]
4. Zielinski, R.; Lyakhov, I.; Jacobs, A.; Chertov, O.; Kramer-Marek, G.; Francella, N.; Stephen, A.; Fisher, R.; Blumenthal, R.; Capala,
J. Affitoxin—A novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors. J. Immunother.
2009, 32, 817–825. [CrossRef] [PubMed]
5. Mechaly, A.; McCluskey, A.J.; Collier, R.J. Changing the receptor specificity of anthrax toxin. mBio 2012, 3, e00088-12. [CrossRef]
[PubMed]
6. Verdurmen, W.P.R.; Luginbühl, M.; Honegger, A.; Plückthun, A. Efficient cell-specific uptake of binding proteins into the
cytoplasm through engineered modular transport systems. J. Control. Release 2015, 200, 13–22. [CrossRef] [PubMed]
7. McCluskey, A.J.; Olive, A.J.; Starnbach, M.N.; Collier, R.J. Targeting HER2-positive cancer cells with receptor-redirected anthrax
protective antigen. Mol. Oncol. 2013, 7, 440–451. [CrossRef]
8. Varughese, M.; Chi, A.; Teixeira, A.V.; Nicholls, P.J.; Keith, J.M.; Leppla, S.H. Internalization of a Bacillus anthracis protective
antigen-c-myc fusion protein mediated by cell surface anti-c-myc antibodies. Mol. Med. 1998, 4, 87–95. [CrossRef]
9. Becker, L.; Verdurmen, W.P.R.; Plückthun, A. Reengineering anthrax toxin protective antigen for improved receptor-specific
protein delivery. BMC Biol. 2020, 18, 100. [CrossRef] [PubMed]
10. Rabideau, A.E.; Pentelute, B.L. Delivery of non-native cargo into mammalian cells using anthrax lethal toxin. ACS Chem. Biol.
2016, 11, 1490–1501. [CrossRef]
11. Wesche, J.; Elliott, J.L.; Falnes, P.Ø.; Olsnes, S.; Collier, R.J. Characterization of membrane translocation by anthrax protective
antigen. Biochemistry 1998, 37, 15737–15746. [CrossRef]
12. Roderer, D.; Schubert, E.; Sitsel, O.; Raunser, S. Towards the application of Tc toxins as a universal protein translocation system.
Nat. Commun. 2019, 10, 5263. [CrossRef]
13. Thoren, K.L.; Worden, E.J.; Yassif, J.M.; Krantz, B.A. Lethal factor unfolding is the most force-dependent step of anthrax toxin
translocation. Proc. Natl. Acad. Sci. USA 2009, 106, 21555–21560. [CrossRef]
14. Zhang, S.; Finkelstein, A.; Collier, R.J. Evidence that translocation of anthrax toxin’s lethal factor is initiated by entry of its N
terminus into the protective antigen channel. Proc. Natl. Acad. Sci. USA 2004, 101, 16756–16761. [CrossRef]
15. Pentelute, B.L.; Sharma, O.; Collier, R.J. Chemical dissection of protein translocation through the anthrax toxin pore. Angew. Chem.
Int. Ed. Engl. 2011, 50, 2294–2296. [CrossRef]
16. Rabideau, A.E.; Liao, X.; Akçay, G.; Pentelute, B.L. Translocation of non-canonical polypeptides into cells using protective antigen.
Sci. Rep. 2015, 5, 11944. [CrossRef] [PubMed]
17. Jiang, J.; Pentelute, B.L.; Collier, R.J.; Zhou, Z.H. Atomic structure of anthrax protective antigen pore elucidates toxin translocation.
Nature 2015, 521, 545–549. [CrossRef] [PubMed]
18. Feld, G.K.; Thoren, K.L.; Kintzer, A.F.; Sterling, H.J.; Tang, I.I.; Greenberg, S.G.; Williams, E.R.; Krantz, B.A. Structural basis for the
unfolding of anthrax lethal factor by protective antigen oligomers. Nat. Struct. Mol. Biol. 2010, 17, 1383–1390. [CrossRef]
19. Beilhartz, G.L.; Sugiman-Marangos, S.N.; Melnyk, R.A. Repurposing bacterial toxins for intracellular delivery of therapeutic
proteins. Biochem. Pharmacol. 2017, 142, 13–20. [CrossRef] [PubMed]
20. Verdurmen, W.P.R.; Mazlami, M.; Plückthun, A. A Biotin ligase-based assay for the quantification of the cytosolic delivery of
therapeutic proteins. In Synthetic Antibodies; Tiller, T., Ed.; Springer: New York, NY, USA, 2017; Volume 1575, pp. 223–236, ISBN
978-1-4939-6855-8.
21. Binz, H.K.; Amstutz, P.; Kohl, A.; Stumpp, M.T.; Briand, C.; Forrer, P.; Grütter, M.G.; Plückthun, A. High-affinity binders selected
from designed ankyrin repeat protein libraries. Nat. Biotechnol. 2004, 22, 575–582. [CrossRef]
22. Kohl, A.; Binz, H.K.; Forrer, P.; Stumpp, M.T.; Plückthun, A.; Grütter, M.G. Designed to be stable: Crystal structure of a consensus
ankyrin repeat protein. Proc. Natl. Acad. Sci. USA 2003, 100, 1700–1705. [CrossRef] [PubMed]
23. Steiner, D.; Forrer, P.; Plückthun, A. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J. Mol.
Biol. 2008, 382, 1211–1227. [CrossRef]
24. Brauchle, M.; Hansen, S.; Caussinus, E.; Lenard, A.; Ochoa-Espinosa, A.; Scholz, O.; Sprecher, S.G.; Plückthun, A.; Affolter, M.
Protein interference applications in cellular and developmental biology using DARPins that recognize GFP and mCherry. Biol.
Open 2014, 3, 1252–1261. [CrossRef]
25. Parizek, P.; Kummer, L.; Rube, P.; Prinz, A.; Herberg, F.W.; Plückthun, A. Designed Ankyrin Repeat Proteins (DARPins) as novel
isoform-specific intracellular inhibitors of c-Jun N-terminal kinases. ACS Chem. Biol. 2012, 7, 1356–1366. [CrossRef] [PubMed]
26. Interlandi, G.; Wetzel, S.K.; Settanni, G.; Plückthun, A.; Caflisch, A. Characterization and further stabilization of designed ankyrin
repeat proteins by combining molecular dynamics simulations and experiments. J. Mol. Biol. 2008, 375, 837–854. [CrossRef]
[PubMed]
27. Arora, N.; Leppla, S.H. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.
J. Biol. Chem. 1993, 268, 3334–3341. [CrossRef]
Pharmaceutics 2021, 13, 1285 13 of 13
28. Wetzel, S.K.; Settanni, G.; Kenig, M.; Binz, H.K.; Plückthun, A. Folding and unfolding mechanism of highly stable full-consensus
ankyrin repeat proteins. J. Mol. Biol. 2008, 376, 241–257. [CrossRef]
29. Schilling, J.; Schöppe, J.; Plückthun, A. From DARPins to LoopDARPins: Novel LoopDARPin design allows the selection of low
picomolar binders in a single round of ribosome display. J. Mol. Biol. 2014, 426, 691–721. [CrossRef] [PubMed]
30. Binz, H.K.; Kohl, A.; Plückthun, A.; Grütter, M.G. Crystal structure of a consensus-designed ankyrin repeat protein: Implications
for stability. Proteins 2006, 65, 280–284. [CrossRef] [PubMed]
31. Liao, X.; Rabideau, A.E.; Pentelute, B.L. Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigen.
ChemBioChem 2014, 15, 2458–2466. [CrossRef]
32. Huang, J.; Craggs, T.D.; Christodoulou, J.; Jackson, S.E. Stable intermediate states and high energy barriers in the unfolding of
GFP. J. Mol. Biol. 2007, 370, 356–371. [CrossRef] [PubMed]
33. Krantz, B.A.; Trivedi, A.D.; Cunningham, K.; Christensen, K.A.; Collier, R.J. Acid-induced unfolding of the amino-terminal
domains of the lethal and edema factors of anthrax toxin. J. Mol. Biol. 2004, 344, 739–756. [CrossRef] [PubMed]
34. Lo, S.Y.; Säbel, C.E.; Mapletoft, J.P.J.; Siemann, S. Influence of chemical denaturants on the activity, fold and zinc status of anthrax
lethal factor. Biochem. Biophys. Rep. 2015, 1, 68–77. [CrossRef] [PubMed]
35. Gupta, P.; Singh, S.; Tiwari, A.; Bhat, R.; Bhatnagar, R. Effect of pH on stability of anthrax lethal factor: Correlation between
denaturation and activity. Biochem. Biophys. Res. Commun. 2001, 284, 568–573. [CrossRef] [PubMed]
